Investment Rating - The report maintains an "Overweight" rating for the electronic industry [3][10]. Core Insights - The demand for eSSD is rapidly increasing, driven by the growth in data centers and AI infrastructure investments, which is expected to sustain high demand for NAND storage products [7][8]. - The electronic industry has shown a recovery in consumer electronics, with new foldable smartphones being released and advancements in AI technology driving high demand for AI infrastructure [9][10]. Market Performance - The electronic industry index decreased by 0.09% last week, underperforming the CSI 300 by 0.92 percentage points [12]. - Year-to-date, the electronic industry index has increased by 47.96%, outperforming the CSI 300 by 29.05 percentage points [12]. Valuation Metrics - The electronic sector's PE (TTM, excluding negative values) is at 61.05X, which is in the 43.55th percentile of the past 10 years [6][12]. - The PB (LF) stands at 5.00X, placing it in the 61.35th percentile of the last decade [6][12]. Industry Dynamics - SanDisk reported a quarterly revenue of $2.308 billion for Q1 FY2026, with a 21% quarter-over-quarter growth and a 23% year-over-year growth [7]. - The average selling price of NAND products has seen a mid-single-digit percentage increase, contributing to revenue exceeding expectations [7]. Investment Recommendations - The report suggests focusing on investment opportunities in AI infrastructure, edge SOC, foldable smartphone supply chains, and storage industry chains [10]. - Specific companies to watch in the AI infrastructure sector include Cambrian, Chipone, and Aojie Technology; in the edge SOC sector, recommended companies are Rockchip, Hengxuan Technology, and Lexin Technology [10].

Investment Rating - The report maintains a "Buy" rating for the medical services industry [6][10][63] Core Views - The medical services sector has experienced a significant decline, with a 2.40% drop this week, underperforming the CSI 300 index by 3.22 percentage points [2][12] - The introduction of policies promoting the integration of artificial intelligence in healthcare is expected to create substantial market opportunities for software and hardware service providers [5][6][62] - The report highlights a clear industrialization blueprint for AI in healthcare, indicating a transformative impact on the medical services sector [6][62] Summary by Sections Industry Performance - The medical services sub-sector index closed at 6859.85 points, down 4.07% this week, while other sub-sectors showed mixed results [2][24] - Notable performers in the medical services sector included Aoyang Health (+5.1%) and Berry Genomics (+3.7%), while companies like Zhaoyan New Drug (-12.2%) and Nanmo Biology (-11.9%) faced significant declines [3][29] Valuation Metrics - The current Price-to-Earnings (PE) ratio for the medical services sector is 32.96X, with a Price-to-Book (PB) ratio of 3.32X [4][30] - The PE ratio has decreased by 3.57X compared to the previous week, and the PB ratio has dropped by 0.13X [4][30] Policy Developments - The Chinese government has issued guidelines to promote the application of AI in healthcare, aiming for widespread implementation by 2030 [5][60][61] - The policy emphasizes the dual focus on regulation and development, benefiting compliant and technologically robust leading enterprises [9][62] Investment Recommendations - The report suggests focusing on high-growth areas such as ADC CDMO and weight-loss drug supply chains, with specific companies like WuXi AppTec and Haoyuan Pharmaceutical highlighted [10][63] - It also recommends monitoring third-party medical testing laboratories and consumer healthcare sectors, particularly in ophthalmology and dentistry [10][63]

Investment Rating - The industry maintains an "Overweight" rating, suggesting a positive outlook for investment opportunities in the traditional Chinese medicine sector [6]. Core Insights - The traditional Chinese medicine sector showed resilience with a 0.81% increase in the index, while the broader pharmaceutical sector declined by 2.4% [2]. - The price-to-earnings (PE) ratio for the traditional Chinese medicine sector is 28.11X, reflecting a slight increase, while the price-to-book (PB) ratio stands at 2.37X, also showing a minor rise [3]. - The recent price index for traditional Chinese medicinal materials has increased by 0.2%, indicating a slight upward trend in the market [4]. - The fourth batch of national procurement for traditional Chinese medicine has been announced, including 90 varieties, which presents both challenges and opportunities for production companies [5]. Summary by Sections Market Performance - The traditional Chinese medicine index closed at 6593.95 points, with a weekly increase of 0.81%, contrasting with declines in other pharmaceutical sectors [2][11]. - Notable performers in the sector include ST HuLuWa, DaRenTang, and ZhongSheng Pharmaceutical, while companies like WanBangDe and QiDi Pharmaceutical lagged [2]. Valuation - The PE ratio for the traditional Chinese medicine sector is currently at 28.11X, with a year-to-date maximum of 30.26X and a minimum of 24.72X [3]. - The PB ratio is at 2.37X, with a maximum of 2.59X and a minimum of 2.17X over the past year [3]. Raw Material Prices - The price index for traditional Chinese medicinal materials has shown a slight increase, with 9 categories rising and 3 falling in the past week [4]. Focus on National Procurement - The fourth batch of national procurement includes 90 varieties, with a focus on products that have significant demand and established clinical applications [5]. Investment Recommendations - The report suggests focusing on three main investment themes: price governance, consumption recovery, and state-owned enterprise reform [6][9]. - Specific recommendations include companies with strong R&D capabilities, those less affected by procurement impacts, and leading brand enterprises in traditional Chinese medicine [9].

Investment Rating - The industry investment rating is maintained at "Overweight" [2][9]. Core Insights - The vaccine industry is currently transitioning from scale expansion to innovation-driven growth, facing short-term pain due to supply-demand imbalance and homogenized competition, but the long-term outlook remains positive driven by policy, demand, and technology [8][9][28]. - Recent breakthroughs in vaccine development for specific populations, such as the quadrivalent influenza vaccine for infants and pregnant women, highlight ongoing innovation in the sector [4][8][9]. - The industry is experiencing structural differentiation among companies, with a focus on innovative and multi-valent products to enhance competitiveness [8][9]. Market Performance - The vaccine sector saw a slight increase of 0.04% last week, while the overall pharmaceutical sector declined by 2.4% [5][11]. - Year-to-date, the vaccine sector has experienced a cumulative decline of 1.57% [5][11]. Company Developments - Companies like Kangtai Biological and Zhonghui Biological are making significant progress in vaccine trials for specific demographics, which could fill market gaps [4][8]. - The latest technical guidelines emphasize the importance of vaccination for high-risk groups, which may drive demand for vaccines [4][8]. Valuation Metrics - The vaccine sector's price-to-earnings (PE) ratio is 99.07X, down 4.97X from the previous period, indicating a high valuation relative to historical standards [7][20]. - The price-to-book (PB) ratio stands at 1.94X, remaining stable, with historical maximum and minimum values of 2.29X and 1.69X respectively [7][20]. Investment Recommendations - The report suggests focusing on companies with strong R&D capabilities and differentiated product offerings, recommending Kangxino and Kanghua Biological as key players to watch [9][28].

Core Insights - The report indicates that inclusive finance business is expected to maintain steady growth, with the People's Bank of China releasing the "China Inclusive Finance Index Analysis Report (2024-2025)" [8][34] - As of June 2025, the balance of inclusive micro and small loans reached 36.09 trillion yuan, reflecting a year-on-year growth of 12.2%, which, although lower than the previous year, remains significantly higher than the general loan growth rate [8][34] - The report highlights that the proportion of inclusive micro and small credit loans is increasing, while the interest rates on these loans are declining [8][34] Industry Performance - The report notes that personal consumption loans, excluding housing loans, reached a balance of 21.29 trillion yuan by September 2025, with a year-on-year growth of 4.2% [8][34] - The report emphasizes that the implementation of special actions to boost consumption since 2025, including fiscal subsidies for personal consumption loans in key areas, is expected to sustain low but steady growth in consumption loans [8][34] Investment Recommendations - The report suggests that the issuance of policy financial tools is likely to boost bank credit demand, with regional banks expected to maintain resilient asset expansion [11][37] - It recommends focusing on state-owned banks for stable high dividend investment value, specifically mentioning Industrial and Commercial Bank of China and Bank of China, as well as opportunities for valuation recovery in joint-stock and regional banks [11][37]

Group 1: Report Overview - The report is a weekly credit bond research report by Xiangcai Securities, dated November 9, 2025 [1][2] Group 2: Industry Investment Rating - No industry investment rating is provided in the report Group 3: Core Viewpoints - The credit bond market showed a mixed performance this week. The primary market saw an increase in issuance and net financing, while the secondary market experienced slower trading and a narrowing of most credit spreads. Looking ahead, the credit bond market is expected to continue its volatile pattern, and investors could consider moderately extending the duration and focusing on the narrowing spread opportunities of 5 - year credit bonds [3][4][6] Group 4: Primary Market of Credit Bonds - From November 3 - 9, 2025, a total of 337 credit bonds (excluding policy - bank bonds) were issued, with a scale of about 457.667 billion yuan, and 155 bonds matured, with a total repayment of about 250.715 billion yuan, resulting in a net financing of about 206.952 billion yuan. The issuance volume increased, and the total repayment decreased, leading to a significant rise in net financing [3][9] - By category, enterprise bonds issued 1 bond with a scale of about 1.6 billion yuan, a net financing of about - 3.066 billion yuan; corporate bonds issued 131 bonds with a scale of about 103.88 billion yuan, a net financing of about 34.5 billion yuan; medium - term notes issued 94 bonds with a scale of 91.915 billion yuan, a net financing of about 30.254 billion yuan; and short - term financing issued 68 bonds with a scale of about 78.532 billion yuan, a net financing of about 29.684 billion yuan [10] Group 5: Secondary Market of Credit Bonds - From November 3 - 9, 2025, the inter - bank market traded 484.495 billion yuan, and the exchange traded 406.434 billion yuan, with a total trading volume of 890.929 billion yuan, indicating slower trading. Secondary trading was mainly concentrated in corporate bonds and medium - term notes [4][17] - Credit bond yields varied. For medium - and short - term notes, short - end yields generally increased, while 3 - year and 5 - year yields showed different changes. Enterprise bond yields of high - grade bonds mostly increased, while those of medium - and low - grade bonds generally decreased. For urban investment bonds, 1 - year yields increased, and 5 - year yields decreased [21] - Due to the general increase in the risk - free rate, most credit spreads narrowed. The narrowing range of medium - and short - term note credit spreads was between 1 - 12BP; enterprise bond credit spreads narrowed by 2 - 9BP; and urban investment bond credit spreads changed between - 11 - 2BP [4][21] Group 6: Credit Bond Default or Extension - No credit bonds defaulted or were extended from November 3 - 9, 2025 [5][22] Group 7: Investment Recommendations - The central bank maintained a net withdrawal this week, the risk - free rate fluctuated weakly, and the credit bond market showed a mixed performance. In terms of the yield structure, short - end yields of credit bonds generally increased, while long - end yields mostly decreased [6][23] - In October, exports decreased by 1.1% year - on - year, affected by the high base last year and the weakening of the "rush - to - export" effect, while imports increased by 1% year - on - year, showing continuous domestic demand recovery. In terms of capital, the central bank's net investment in open - market treasury bond trading in October was 20 billion yuan, which, although smaller than the same period last year, helps release liquidity in the long run. Coupled with the alleviation of banks' liability - side pressure, most capital interest rates decreased [6][23] - Looking ahead, the credit bond market is expected to continue its volatile pattern. Investors could consider moderately extending the duration and focusing on the narrowing spread opportunities of 5 - year credit bonds [6][23]

Core Insights - The Alpha momentum strategy underperformed, with a cumulative decline of 0.57% from November 3 to November 7, 2025, while the HS300 index rose by 0.82%, resulting in an excess return of -1.40% [2][8] - The Alpha reversal strategy showed a cumulative increase of 0.73% during the same period, slightly underperforming the HS300 index, which also increased by 0.82%, leading to an excess return of -0.09% [2][12] - The industry Alpha portfolio experienced a cumulative decline of 2.11% from November 1 to November 7, 2025, compared to the HS300's increase of 0.82%, resulting in an excess return of -2.94% [3][26] Market Trend Analysis - The performance of the Alpha momentum and reversal strategies can be used to gauge market conditions. If both strategies outperform the index, with the reversal strategy outperforming the momentum strategy, the market is in a bull phase. Conversely, if neither strategy shows a clear advantage, the market is likely in a bear phase or transitioning from bull to bear [4][19] - The current weekly performance indicates weak momentum indicators, with the momentum strategy underperforming both the benchmark and the reversal strategy. However, there is some upward momentum expected in the near term, with projections for the Shanghai Composite Index to fluctuate between 3930 and 4060 points for the week of November 10 to November 14, 2025 [5][20] Industry Alpha Selection Strategy - The report outlines an industry Alpha selection strategy based on historical Alpha values across different time frames (1 month, 2 months, 3 months, 6 months, and 1 year). The strategy involves rolling investments, selecting the top 5 industries based on Alpha values for momentum and the bottom 5 for reversal [25]

Quantitative Models and Construction - **Model Name**: Industry Allocation Model Based on Profit Growth Rate **Model Construction Idea**: The model uses profit growth rate as the primary criterion for industry selection, supplemented by valuation and trading crowding metrics as risk indicators[7][27][29] **Model Construction Process**: 1. **Profit Growth Metrics**: - Single-quarter net profit year-on-year growth rate - Marginal change in single-quarter net profit year-on-year growth rate Formula for marginal change: $ \text{Marginal Change} = \text{2025 Q3 Single-quarter YoY Growth} - \text{2024 Q3 Single-quarter YoY Growth} $[15][29] 2. **Valuation Metric**: - Historical PE_TTM percentile (2020 to present) is used to measure valuation levels across industries[18][21][29] 3. **Trading Crowding Metric**: - Standard deviation of turnover rate over the past three months is calculated to assess trading crowding[6][24][29] 4. **Comprehensive Scoring**: - Each metric is ranked, and weights are assigned: - Profit growth metrics: 0.3 each - Risk metrics (valuation and trading crowding): 0.2 each Formula for comprehensive scoring: $ \text{Comprehensive Score} = 0.3 \times \text{Net Profit YoY Growth} + 0.3 \times \text{Marginal Change} + 0.2 \times \text{Valuation Percentile} + 0.2 \times \text{Turnover Rate Std Dev} $[31][32] **Model Evaluation**: The model effectively identifies industries with high profit growth and moderate risk levels, providing actionable allocation recommendations[7][27][32] Model Backtesting Results - **Industry Allocation Model**: - Portfolio return: 2.38% - Benchmark (Wind All A Index) return: 0.63% - Excess return: 1.75%[7][32] Quantitative Factors and Construction - **Factor Name**: Profit Growth Rate **Factor Construction Idea**: Measures industry profitability through single-quarter net profit growth and marginal changes in growth rates[7][29] **Factor Construction Process**: 1. Single-quarter net profit year-on-year growth rate 2. Marginal change in single-quarter net profit year-on-year growth rate Formula: $ \text{Marginal Change} = \text{2025 Q3 Single-quarter YoY Growth} - \text{2024 Q3 Single-quarter YoY Growth} $[15][29] **Factor Evaluation**: Effectively captures industries with strong profitability and growth momentum[7][29] - **Factor Name**: Valuation Percentile **Factor Construction Idea**: Uses historical PE_TTM percentiles to compare valuation levels across industries[18][21] **Factor Construction Process**: 1. Calculate PE_TTM for each industry 2. Determine historical percentile (2020 to present) for PE_TTM values[18][21] **Factor Evaluation**: Provides a standardized comparison of valuation levels across industries, mitigating biases from absolute PE differences[21][29] - **Factor Name**: Turnover Rate Standard Deviation **Factor Construction Idea**: Measures trading crowding by assessing the volatility of turnover rates over the past three months[6][24] **Factor Construction Process**: 1. Calculate daily turnover rates for each industry over the past three months 2. Compute standard deviation of turnover rates[6][24] **Factor Evaluation**: Identifies industries with extreme trading behaviors, serving as a risk indicator[6][24] Factor Backtesting Results - **Profit Growth Rate Factor**: - Steel: 203.31% YoY growth, 380.75% marginal change[10][15] - Electronics: 57.42% YoY growth, 59.99% marginal change[10][15] - Media: 58.63% YoY growth, 82.75% marginal change[10][15] - Defense: 29.52% YoY growth, 83.60% marginal change[10][15] - Utilities: 17.77% YoY growth, 19.81% marginal change[10][15] - **Valuation Percentile Factor**: - Steel: 99.72%[21][29] - Electronics: 98.94%[21][29] - Media: 90.40%[21][29] - Defense: 97.10%[21][29] - Utilities: 55.31%[21][29] - **Turnover Rate Standard Deviation Factor**: - Steel: 50.48%[6][29] - Electronics: 96.51%[6][29] - Media: 84.50%[6][29] - Defense: 82.79%[6][29] - Utilities: 25.21%[6][29]

Financial Engineering - The report highlights the tracking of an outperforming stock selection strategy, indicating a focus on stocks with net profit growth exceeding expectations and analyst forecasts [1] Active Quantitative Fund Performance - For the week of October 24 to October 31, 2025, the median return of active quantitative funds was 0.09%, while the CSI 300 Index returned -0.43% and the Wind All A Index returned 0.41% [2] - Year-to-date, the median return of active quantitative funds stands at 28.88%, compared to 17.94% for the CSI 300 Index and 26.38% for the Wind All A Index [2] - Top-performing active quantitative funds this week had returns between 3% and 6%, primarily concentrated in the power equipment sector, while underperforming funds had returns between -2% and -5%, mainly focused on the electronics sector [2] Outperforming Stock Selection Strategy - The outperforming stock selection strategy is constructed based on two indicators: year-on-year net profit exceeding expectations and analyst forecasts exceeding expectations [3] - The strategy utilizes the Wind All A index as the underlying stock pool, combining the top 50 stocks based on analyst forecasts and the top 50 stocks based on net profit growth to form the final stock pool [4] - For the week of October 24 to October 31, 2025, the strategy yielded a return of -0.98%, underperforming the Wind All A Index, which returned 0.41% [4] - In the previous month, the strategy achieved a return of 1.34%, outperforming the Wind All A Index, which returned -0.04% [4] - Year-to-date, the strategy's return is 46.11%, significantly higher than the Wind All A Index's return of 26.38%, resulting in an excess return of 19.73% [4] Summary and Investment Recommendations - The report notes that top-performing active quantitative funds are concentrated in the power equipment sector, while high-return funds this year are focused on the electronics sector [5] - The outperforming stock selection strategy's return for the week was -0.98%, while its year-to-date return is 46.11% [5] - In November 2025, the strategy selected 30 stocks, primarily from the machinery and equipment sector [5] - The highest return this year was from Cangge Mining (000408.SZ), with a return of 116.30%, categorized under non-ferrous metals and energy metals [5]

Macro Insights - The U.S. federal government has entered its 35th day of a shutdown, matching the longest shutdown record in U.S. history, with no agreement reached between the Democratic and Republican parties on a temporary funding bill [2] - The State Council announced a nine-day holiday for the Spring Festival in 2026, leading to a significant increase in online travel bookings for both New Year's and Spring Festival periods, particularly for popular tourist destinations [2] Real Estate Market - Since 2019, the proportion of existing residential sales has increased from 10% to 33% at the beginning of this year, with over 30 provinces and cities in China implementing pilot programs for existing home sales [3] Financial Engineering - From October 27 to October 31, the Shanghai Composite Index closed at 3954.79, with increased trading volume compared to the previous week. The Shenzhen Component Index closed at 13378.21, also with increased trading volume [6] - The 50ETF saw a weekly decline of 1.00%, while the Southern CSI 500ETF increased by 0.91% during the same period [8] - The average daily trading volume of 50ETF options decreased, while total open interest increased, indicating a mixed sentiment in the options market [7] Investment Strategy - The market showed a divergence in performance among different ETFs, with the 50ETF underperforming and the 500ETF showing strength. The PCR indicators reflected this divergence, with a decrease in put option holdings for the weaker ETFs [8][9] - The overall market sentiment appears to be cautious, with expectations of continued volatility but stable implied volatility levels, suggesting a potential strategy of shorting on rallies [9]